Form 4: Veracyte CFO Rebecca Chambers Reports Acquisition and Disposal of Common Stock

Rebecca Chambers, CFO of Veracyte, Inc., reports the acquisition of 4,318 shares of common stock and the disposal of 2,189 shares to cover tax obligations.

Summary

• On March 15, 2024, Rebecca Chambers, the Chief Financial Officer of Veracyte, Inc., acquired 4,318 shares of common stock.
• These shares were obtained through the vesting of restricted stock units (RSUs) earned upon achieving performance goals for the year ending December 31, 2023.
• The RSUs vested on March 15, 2024, as certified by the Compensation Committee of the Board of Directors.
• On the same day, Ms. Chambers disposed of 2,189 shares of common stock to satisfy tax withholding obligations related to the vesting of the performance stock units.
• This disposal was not a sale by Ms. Chambers.
• Following these transactions, Ms. Chambers beneficially owns 146,702 shares of Veracyte common stock.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing related to executive compensation. The sentiment is neutral as it reflects routine transactions.

Positives

• The acquisition of shares reflects the achievement of performance goals, which could be seen as a positive indicator of company performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates activity related to equity compensation for Veracyte's CFO.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they involve a relatively small number of shares.

Key Dates